Integral Molecular News

Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes

FOX, ET AL. 2019. SCI IMMUNOL, 4(32): EAAV5062

Read More

Upcoming Events

ACT
Nov 15th-18th
San Antonio, Texas

PEGS Europe
Nov 17th-19th
Lisbon, Portugal

Antibody Engineering & Therapeutics
Dec 13th-16th
San Diego, CA